Rothschild Investment LLC’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$744K Buy
3,970
+3,929
+9,583% +$574K 0.03% 491
2026
Q1
$3.99K Buy
41
+39
+1,950% +$3.94K ﹤0.01% 2175
2025
Q4
$159 Buy
+2
New +$131 ﹤0.01% 3147
2025
Q2
– Sell
-280
Closed -$9.9K – 3161
2025
Q1
$9.9K Buy
280
+100
+56% +$4.06K ﹤0.01% 1174
2024
Q4
$7.87K Buy
180
+25
+16% +$1.26K ﹤0.01% 1204
2024
Q3
$7.03K Buy
155
+90
+138% +$3.92K ﹤0.01% 1195
2024
Q2
$2.52K Buy
65
+50
+333% +$1.87K ﹤0.01% 1326
2024
Q1
$483 Buy
+15
New +$445 ﹤0.01% 1372

Other funds holding RVMD

Rothschild Investment LLC's RVMD Position: Q2 2026 in Review

Rothschild Investment LLC increased its Revolution Medicines (RVMD) stake by 9,583% in Q2 2026, buying an estimated $574K and bringing the position to 3,970 shares worth $744K. The position accounts for 0.03% of the portfolio, ranked #491.

Rothschild Investment LLC first reported a position in RVMD in Q1 2024 and has held it in 8 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Rothschild Investment LLC held 3,970 shares of Revolution Medicines worth $744K as of Q2 2026.
  • Rothschild Investment LLC bought 3,929 Revolution Medicines shares in Q2 2026, an estimated $574K.
  • Revolution Medicines made up 0.03% of Rothschild Investment LLC's portfolio in Q2 2026, its #491 holding.
  • Rothschild Investment LLC first reported a position in Revolution Medicines in Q1 2024 and has held it in 8 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.